Wavelength Pharmaceuticals Ltd.

www.wavelengthpharma.com

Formerly Perrigo API, Chemagis ; Now SEQENS Israel

High-Tech Company

Acquired by SK Capital Partners

TECH VERTICALS

Biotechnology, Industrial, Life Sciences, MedTech

General Data

Sector	Biomed
Company Stage:	Revenue Growth
Established	1987
Number of Employees	90
Employees in Israel	65

DESCRIPTION

Wavelength Pharmaceuticals (formerly known as Perrigo API) is a world-class developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and select Finished Dosage Forms (FDFs).

TECHNOLOGY

Strong in complex chemistry, innovative process development, crystalline forms and particle design, Wavelength Pharmaceuticals focuses on differentiated products that require sophisticated manufacturing processes. The company offers a best-in-class solution, providing its customers comprehensive technical and in-depth regulatory support across the entire product lifecycle, from project inception to commercial production.

Wavelength offers abroad array of products that require specialized capabilities in complex synthesis, high potency, steroids and cytotoxics. We provide our wide customer base a diverse portfolio of differentiated products across a large variety of therapeutic indications and dosage form applications, including inhalers, nasals, semi-solid topicals, transdermals, parenterals, oral solids and liquids.

	TARGET MARKETS
	Healthcare market

	BUSINESS MODEL
	B2B

REMARKS

Date	Remark
17/12/2021	SK Capital Partners completes acquisition of SEQENS and merges Wavelength Pharmaceuticals.
18/02/2021	Wavelength Acquires a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India. Vanamali Organics provides high quality customized process development and manufacturing services using advanced technologies and a quality-by-design approach to deliver eco-efficient regulatory compliant chemistry.
01/11/2017	The company is acquired by SK Capital, and renamed Wavelength Pharmaceuticals.
01/01/2005	Perrigo acquires Chemagis. The active pharmaceutical ingredients unit was bought by Perrigo as part of the acquisition of Agis. In 2013 the company name was changed from "Chemagis LTD" to "Perrigo API LTD".
01/01/1987	Chemagis, a developer and manufacturer of Active Pharmaceutical Ingredients (API), is established as part of Agis Industries Group.

CONTACT INFO

Expand / Collapse All

Main Address: Petach Tikva, Israel

Address	Ofer Park, Brosh building, 4th floor 94 Shlomo Shmeltzer Road
City	Petach Tikva
Country	Israel
Zip	4970602

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Beer Sheva, Israel

Address	Neot-Hovav Industrial Park
POB	3593
City	Beer Sheva
Country	Israel
Zip	8413502

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Barcelona, Spain

Address	126 Ronda del General Mitre
City	Barcelona
Country	Spain
Zip	08021

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Wayne, United States

Address	1700 Route 23 North Suite 130
City	Wayne
State/Province	NJ
Country	United States
Zip	07470

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Frederic Kahn	VP, Sales
Mr. Moshe Arkin	Founder

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Nov. 22, 2017

Revenue Growth

abCDe

Acquired

Nov. 15, 2004

Initial Revenues

abCDe

	Acquisitions made by Wavelength Pharmaceuticals

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	N/A	Feb. 18, 2021	abCDe	Wavelength Acquires a majority stake in Vanamali Organics.

Last Updated:	abCDe
IVC Number:	abCDe